Liu Ying, Song Zan, Liu Yajie, Ma Xubin, Wang Wang, Ke Yu, Xu Yichao, Yu Dequan, Liu Hongmin
State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Advanced Drug Preparation Technologies, Henan Key Laboratory of Drug Quality Control & Evaluation, School of Pharmaceutical Sciences, Zhengzhou University, Ministry of Education of China, Zhengzhou 450001, China.
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Acta Pharm Sin B. 2021 Jun;11(6):1513-1525. doi: 10.1016/j.apsb.2021.05.006. Epub 2021 May 13.
Ferroptosis is a type of cell death accompanied by iron-dependent lipid peroxidation, thus stimulating ferroptosis may be a potential strategy for treating gastric cancer, therapeutic agents against which are urgently required. Jiyuan oridonin A (JDA) is a natural compound isolated from Jiyuan with anti-tumor activity, unclear anti-tumor mechanisms and limited water solubility hamper its clinical application. Here, we showed , a new JDA derivative, inhibited the growth of gastric cancer cells. Subsequently, we discovered for the first time that induced ferroptosis. Importantly, compound decreased GPX4 expression and overexpressing GPX4 antagonized the anti-proliferative activity of . Furthermore, we demonstrated that caused ferrous iron accumulation through the autophagy pathway, prevention of which rescued induced ferrous iron elevation and cell growth inhibition. Moreover, exhibited more potent anti-cancer activity than 5-fluorouracil in gastric cancer cell line-derived xenograft mice models. Patient-derived tumor xenograft models from different patients displayed varied sensitivity to , and GPX4 downregulation indicated the sensitivity of tumors to . Finally, exhibited well pharmacokinetic characteristics. Overall, our data suggest that inducing ferroptosis is the major mechanism mediating anti-tumor activity of , and will hopefully serve as a promising compound for gastric cancer treatment.
铁死亡是一种伴随着铁依赖性脂质过氧化的细胞死亡类型,因此刺激铁死亡可能是治疗胃癌的一种潜在策略,迫切需要针对此的治疗药物。济源冬凌草甲素(JDA)是从济源分离出的一种具有抗肿瘤活性的天然化合物,其抗肿瘤机制尚不清楚,且水溶性有限,阻碍了其临床应用。在此,我们展示了一种新的JDA衍生物抑制胃癌细胞的生长。随后,我们首次发现其诱导铁死亡。重要的是,该化合物降低了GPX4的表达,而过表达GPX4拮抗了其抗增殖活性。此外,我们证明该化合物通过自噬途径导致亚铁积累,阻止这一过程可挽救其诱导的亚铁升高和细胞生长抑制。此外,在胃癌细胞系衍生的异种移植小鼠模型中,该化合物比5-氟尿嘧啶表现出更强的抗癌活性。来自不同患者的患者来源肿瘤异种移植模型对该化合物表现出不同的敏感性,GPX4下调表明肿瘤对该化合物的敏感性。最后,该化合物表现出良好的药代动力学特征。总体而言,我们的数据表明诱导铁死亡是介导该化合物抗肿瘤活性的主要机制,该化合物有望成为治疗胃癌的有前景的化合物。